Syntaxin 7 modulates seizure activity in epilepsy

Neurobiol Dis. 2023 Jun 1:181:106118. doi: 10.1016/j.nbd.2023.106118. Epub 2023 Apr 7.

Abstract

The exact pathogenesis of epilepsy, one of the most common and devastating diseases of the nervous system, is not fully understood. Syntaxin7 (STX7) is a member of the SNARE superfamily, which mediates membrane fusion events in all cells. However, the role STX7 plays in epilepsy remains unclear. Therefore, this study investigates the role of STX7 in epilepsy. Our study found that the expression of STX7 was reduced in the epileptic brain and that overexpression of STX7 decreased the susceptibility to epileptic seizures and alleviated epileptic activity in a kainic acid-induced model and pentylenetetrazole-induced kindling model of epilepsy, whereas the downregulation of STX7 showed opposite effects. Whole-cell patch-clamp recordings showed that STX7 does not affect the intrinsic excitability of neurons, but rather the excitation/inhibition ratio mediated by affecting the release of presynaptic γ-aminobutyric acid neurotransmitters. Transmission electron microscopy results showed that STX7 did not affect the density of inhibitory synapses but could affect the density of inhibitory vesicles. Taken together, these results reveal a previously unknown function of STX7 in epilepsy and suggest that STX7 may serve as a novel target for epilepsy therapy.

Keywords: Epilepsy; GABA; Synaptic transmission; Synaptic vesicle; Syntaxin 7.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carrier Proteins
  • Epilepsy* / metabolism
  • Humans
  • Mice
  • Neurons / metabolism
  • Qa-SNARE Proteins / metabolism
  • Seizures / metabolism

Substances

  • Carrier Proteins
  • Qa-SNARE Proteins